NTM drug discovery: status, gaps and the way forward - ScienceDirect

Drug Discovery for Non-tuberculous Mycobacteria: Recent Updates

Structural basis for specific inhibition of salicylate synthase

A strip-based assay for detection of CrfA enzyme activity to

Mycobacterium abscessus: Trends in Microbiology

NTM drug discovery: status, gaps and the way forward. - Abstract

Trend of nontuberculous mycobacteria species and minimal

NTM drug discovery: status, gaps and the way forward. - Abstract

Novel Integrated Platform Promises To Accelerate Drug Discovery

Strategies for drug target identification in Mycobacterium leprae

Eradication of Nontuberculous Mycobacteria in People with Cystic

A novel chemogenomic discovery platform identifies bioactive hits

Lipolytic enzymes inhibitors: A new way for antibacterial drugs